CORONAVIRUS DISEASE SURVIVAL TIME MODEL FOR FORECASTING
Journal of Pharmaceutical Negative Results
; 14(3):155-165, 2023.
Article
in English
| Academic Search Complete | ID: covidwho-2318325
ABSTRACT
The term "survival analysis" refers to statistical techniques for data analysis where the time until the occurrence of the desired event serves as the outcome variable. Time to event analysis is another name for survival analysis. Applications for survival analysis are fairly broad and include things like calculating a population's survival rate or contrasting the survival of two or more groups. Cox regression analysis is a highly well-liked and frequently applied technique among them. Data on disease states are typically obtained at random epochs or at periodic epochs during follow-up in research looking at biological changes between states of Coronavirus infection and the start of COVID-19 in the human immune system. For instance, after the COVID enters a person's bloodstream by a route of transmission, it progresses through numerous stages that are linked to the depletion of B cells before becoming COVID-19. This study presents the Cox's approach for simulating the link between variables influencing the development of two disease states, namely I= the time epoch of COVID infection and P= the time epoch of COVID-19. Incubation period (IP) or survival time is the precise interval of time between "P and I." It is shown how Cox's model works with several personal infective factors and how well it can estimate the percentage of COVID-19 victims with the same completed length of IP. Such forecast values are then established for a synthetically simulated data set. [ FROM AUTHOR] Copyright of Journal of Pharmaceutical Negative Results is the property of ResearchTrentz and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full . (Copyright applies to all s.)
Full text:
Available
Collection:
Databases of international organizations
Database:
Academic Search Complete
Type of study:
Prognostic study
Language:
English
Journal:
Journal of Pharmaceutical Negative Results
Year:
2023
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS